chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Since receiving the Moderna series I have felt increased heart rate, laziness, irregular/sputtering heartrate. I remember a particular instance where I was driving down the interstate and thought I was having a heart attack. My heart felt like it was pounding out of my chest for what felt like 10 seconds. I am a 27 year-old male with no other health conditions.
Patient's whole upper arm and shoulder began hurting immediately after vaccination and has continued to hurt. She has had trouble lifting or reaching with the arm. Patient stated she works at Hospital and questioned a nurse practitioner who felt the injection was given too high but should resolve within 6 weeks.
stiff neck; a rash on the vaccine arm, that spread rapidly over next few days. It is red, 6 inches by 4 inches; a rash on the vaccine arm, that spread rapidly over next few days. It is red, 6 inches by 4 inches; headache; felt tired and exhausted; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff neck), RASH PRURITIC (a rash on the vaccine arm, that spread rapidly over next few days. It is red, 6 inches by 4 inches), VACCINATION SITE RASH (a rash on the vaccine arm, that spread rapidly over next few days. It is red, 6 inches by 4 inches), FATIGUE (felt tired and exhausted) and HEADACHE (headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease, Diabetes and Hair loss. Concomitant products included METFORMIN for Diabetes, SPIRONOLACTONE for Hair loss, LEVOTHYROXINE SODIUM (SYNTHROID) for Hashimoto's disease, ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced FATIGUE (felt tired and exhausted). On 05-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff neck), RASH PRURITIC (a rash on the vaccine arm, that spread rapidly over next few days. It is red, 6 inches by 4 inches), VACCINATION SITE RASH (a rash on the vaccine arm, that spread rapidly over next few days. It is red, 6 inches by 4 inches) and HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) for Muscle pain, at an unspecified dose and frequency and HYDROCORTISONE for Rash, at an unspecified dose and frequency. On 30-Jan-2021, FATIGUE (felt tired and exhausted) had resolved. On 16-Feb-2021, HEADACHE (headache) had resolved. At the time of the report, MUSCULOSKELETAL STIFFNESS (stiff neck), RASH PRURITIC (a rash on the vaccine arm, that spread rapidly over next few days. It is red, 6 inches by 4 inches) and VACCINATION SITE RASH (a rash on the vaccine arm, that spread rapidly over next few days. It is red, 6 inches by 4 inches) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    Treatment information include an antihistamine cream for the rash.
Swelling; Pain; This is a spontaneous report from a contactable other health professional via a Pfizer sales representative. A patient of unspecified age and gender received meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration, on an unspecified date, at single dose, for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced swelling and pain both on an unspecified date with outcome of unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Petechial rash noted to dorsal aspect of b/l feet, not including legs/calves or soles of feet.  nontender, nonswollen
After a rough night of fever, chills and muscle pain I awoke in the morning and poured some orange juice. Suddenly I passed out and fell on the kitchen floor, injuring my right ankle.
This initial non-serious spontaneous case, received on 06-Dec-2017 reported by a pharmacist and concerns a female patient of unspecified age. The patient's historical condition included stroke recently. The patient's concomitant medications included NORCO for pain, LIPITOR for cholesterol, ZESTRIL for blood pressure, EFFEXOR and BUSPAR for anxiety, Aspirin. On 03-Nov-2017, the patient received FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right deltoid, batch number: 195215, expiry date: 30-Apr-2018). It was reported that, the pharmacist administered the vaccine by raising the arm higher than normal, possibly injected into the joint. As the pain continued, the patient visited ER where she was given a pain shot. On an unspecified date, after vaccination the patient had pain in her arm and numb sometimes. At the time of this report, the patient had not yet recovered from the event. The reporter assessed the causality for the events (injection site pain and numbness of upper arm) as related to the suspect vaccine.
Information has been received from a licensed visiting nurse and a medical assistant concerning an 8 week old male with reflux and no known drug allergy who on 11-APR-2011 was vaccinated orally with his first dose of 2 ml ROTATEQ (lot # 668964/1200Z). Secondary suspect therapy included a dose of RECOMBIVAX HB (lot # 669600/0230AA, thimerosal-free) on 11-APR-2011. Concomitant therapy included nizatidine, PENTACEL (lot # C382AA) and PREVNAR (lot # E89951). On 13-APR-2011 the patient experienced bloody stool, diarrhea, fever and fuzziness after receiving the vaccine. The patient was rushed to the hospital emergency room and was kept overnight. The patient was released from the hospital on 14-APR-2011. No discharge summary was available. Results of stool culture performed while hospitalized were not received. Stool heme was tested in the office which showed positive. It was unspecified what treatment was given to the patient. At the time of reporting, the patient's bloody stool persisted and the outcome of diarrhea, fever and fuzziness was unknown. It was unknown if the events were disabling or life threatening. Additional information has been requested.
One month after the vaccine I started to get Hot Flashes followed by pain. The pain lasted for six hours and then went away. The pain is all over my body The process returned after a week or so and it has continued intermittently since then. The cycle is always the same. I get a hot flash and then the pain starts. As time goes on it is happening more often and the pain lasts for longer. I get really hot and sweat for about 15 minutes and then the pain starts. It builds up to being a more severe pain which has been lasting up to 24 hours. It has been getting less often and for slightly shorter periods of pain. Just in the last two weeks I started to get pain at the injection site, and it is starting to affect my whole arm around the area. It is like a muscle pain. I have consulted my doctor and She prescribed Tramadol. It seems to help but over the counter medications don't seem to work.
Pt come in for sick visit, c/o sore throat, ear pain and rash. Dx with chicken pox by MD, No tx prescribed.
had covid; had covid; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (Unknown). The reporter is the patient.  An 88-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Sep2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "had covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course:  The patient was asking how long does the Paxlovid would stay in system after taken it because she was taking statin. She wanted to make sure, stated she was not even sure that she was comfortable taking a Paxlovid, she do not know even if I needed to take it, because she was 88 years old and she was not even sure if she had covid, somebody told her that when you test with those quick covid tests they were not always accurate, and she should had not been beating herself up and she was fine. She wanted to make sure when can she took her statin and she was looking forward when she can took her vaccine again and she was fully vaccinated and that she even had covid. She was fully vaccinated and when she can get another booster. (Stated that she had last covid vaccine booster in Sep.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
had a vaccine and still got them/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that he/she had seen shingles, and they looked worse than leprosy and he/she knew a person (patient) who got the Shingle vaccine and still got shingles sometime later. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Rash and raised hard area at injection site. Getting continually worse over time Still painful over 1 week after vaccine Still feeling tired and lethargic over 1 week after vaccine Still feel foggy in the mind over 1 week after vaccine
Mother reports high fever after Tylenol (although she never took temperature). Swelling, no redness in bilateral legs and non-stop crying for 3 hours.
Large red rash appeared exactly 1 week after receiving the first moderna shot, on the same arm that it was given in. The rash was consistent in color (did not have any lesions, bumps, dark or lighter spots, etc) and slightly painful and annoying.  It had a diameter of at least 2 inches, and went away within 3-4 days. The rash was concerning since the patient is not prone to allergic skin reactions to anything, and does not have any allergies of any sort. Moderna dose #2 was then given in the right arm and did not produce this rash
Tested PCR positive for COVID on 9/27/21 after being fully vaccinated.
15 minutes after FluMist administration states skin became red and felt as if something was crawling on skin. Coworkers state was momentarily mentally foggy (disoriented). States episode last 15-20 minutes and felt bad the rest of day. No treatment.
2 days after vaccine developed redness, pain, warmth at injection site >4cm along with fever 101F.  Four days after developed rash to abdomen.
EXPIRED PRODUCT ADMINISTERED; HEADACHE; TIREDNESS; This spontaneous report received from a patient concerned an adult male. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and other pre-existing medical conditions included the patient had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-APR-2021, the subject experienced headache. On 13-APR-2021, the subject experienced tiredness. On an unspecified date, the subject experienced expired product administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from headache, and tiredness, and the outcome of expired product administered was not reported. This report was non-serious.
Clients left third finger became white within one minute of injection and client shared finger was numb.  Left arm from forearm  to distal fingers cold to touch.  Left upper arm at vaccination site warm to touch.  Hand grasps equal.  BP - 120/80 and pulse 80.  Client began shaking uncontrollably.  Chest and back contained blotchy non-raised rash.  Epinephrine given at 4:56 PM  and ambulance summoned.  Left finger went from white to ruby red with cyanotic fingernail post epinephrine.  Shaking continued.  O2 saturation level not registering per oximeter.  Client anxious, apprehensive.  Second dose of Epinephrine give at 5:01 PM .    Client complaining of severe itching and rash continued.  Benadyl given at 5:10 PM. Complained of chest tightness at 5:12 PM.  Third dose of Epinephrine given at 5:14 PM.   Nausea ensued.  Ambulance arrived at 5:30 PM and transported to ER.
Typical "Covid arm" on left arm starting 8 days after first shot, raised oval itchy red spot about 3-4 inches.  Swollen, achy and warm to touch.  Subsided in a week.  Still getting next shot, in other arm!
Red spot size of 2 silver dollars at site of injection. Itching but otherwise no symptoms.
Patient reports itchiness, redness, warmth, and swelling that extends from Left Deltoid (injection site) to left elbow.
redness extending from the site down her arm; Itching; This case was reported by a pharmacist via call center representative and described the occurrence of erythema of extremities in a 79-year-old female patient who received Herpes zoster (Shingrix) (batch number 2B3P2, expiry date 10th May 2022) for prophylaxis.   On 14th December 2019, the patient received the 2nd dose of Shingrix. On 15th December 2019, 1 days after receiving Shingrix, the patient experienced injection site itching. On 16th December 2019, the patient experienced erythema of extremities. On an unknown date, the outcome of the erythema of extremities and injection site itching were unknown.   It was unknown if the reporter considered the erythema of extremities and injection site itching to be related to Shingrix.  Additional case details were reported as follows: The patient received Shingrix and experienced itching at the site the following day and developed redness extending from the site down her arm.  The reporter consented to follow up. No further details were provided at the time of this call.
Chills; Fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (Chills) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 09L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced CHILLS (Chills) and PYREXIA (Fever). At the time of the report, CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.    The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-017817, US-MODERNATX, INC.-MOD-2021-010482, US-MODERNATX, INC.-MOD-2021-017800, US-MODERNATX, INC.-MOD-2021-017750, US-MODERNATX, INC.-MOD-2021-010477, US-MODERNATX, INC.-MOD-2021-017674, US-MODERNATX, INC.-MOD-2021-019767, US-MODERNATX, INC.-MOD-2021-019740, US-MODERNATX, INC.-MOD-2021-019718, US-MODERNATX, INC.-MOD-2021-017795, US-MODERNATX, INC.-MOD-2021-028790, US-MODERNATX, INC.-MOD-2021-047944 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-017817:Crosslinked (MOD21-018034) US-MODERNATX, INC.-MOD-2021-010482:Crosslinked (MOD21-018048) US-MODERNATX, INC.-MOD-2021-017800:Crosslinked (MOD21-018071) US-MODERNATX, INC.-MOD-2021-017750:Crosslinked (MOD21-018080) US-MODERNATX, INC.-MOD-2021-010477:Crosslinked (MOD21-018089) US-MODERNATX, INC.-MOD-2021-017674:Crosslinked (MOD21-018092) US-MODERNATX, INC.-MOD-2021-019767:Crosslinked (MOD21-018097) US-MODERNATX, INC.-MOD-2021-019740:Crosslinked (MOD21-018102) US-MODERNATX, INC.-MOD-2021-019718:Crosslinked (MOD21-018111) US-MODERNATX, INC.-MOD-2021-017795:Crosslinked (MOD21-018119) US-MODERNATX, INC.-MOD-2021-028790:Crosslinked (MOD21-018124) US-MODERNATX, INC.-MOD-2021-047944:Crosslinked (MOD21-018126)
pt recvd flu vax & 6 days later was noted to have a low white count & no neutrophils; meds were discontinued & pt was treated w/Neupogen; Bone marrow biopsy was performed, but results are unknown;
I developed hives all over my body that have been recurring daily for nearly 5 months. This has also been associated with increased diarrhea.
Patient with 3 COVID Moderna vaccinations with incidental positive COVID test upon admission.  Provider d/c note below:  "74 y.o. female with PMHx of SLE, HTN, HLD, T2DM, COPD, OSA, and CKD3 here with GI bleed. Patient has been feeling fatigued for the past three days. Developed sudden bright red bowel movements today. On arrival to the ED patient was hypotensive after 3L. Initial Hgb was 10.3 but 2 hours later it dropped to 8.8. Given x1 unit of PRBCs. Patient remained hypotensive after the first unit. CT abdomen and pelvis showed multiple segments of dilated small bowel with mural thickening concerning for IBD. Dr. was consulted who plans on colonoscopy in AM. Patient had another dark bloody bowel movement with clots in the ED. Given continued hypotension patient was admitted to the ICU for further monitoring.    Patient has never had GI bleeding in the past and ha snot had a colonoscopy. Has had appendectomy, cholecystectomy and hysterectomy. Not on blood thinners. Is not on any immunologics or steroids for her Lupus given intolerance to side effects. Did not take home BP meds today (HPI per Dr. )   Hospital Course: No notes on file Concern for upper GI bleed -hematochezia in ER, hematemesis in ICU, Gastroenterology following, Hgb stable post transfusion though she is still having black stools. She is covid positive and GI wishes to wait till she is out of isolation. I discussed with GI and they said ok to discharge her on bid ppi with close follow up with GI for out patient EGD - which they will arrange. I will check CBC on 7/21, avoid NSAIDS and hold ASA till f/u with GI.   Hemorrhagic shock secondary to upper GI bleed -s/p 2 units PRBC, REquired pressors but now off Levophed.   COVID-19 infection -incidental finding, x3 vaccination, asymptomatic respiratory, transient hypoxemia secondary hemorrhagic anemia, resolved, no indication for immunologics   Discharge Exam: General - Elderly female, not in obvious distress HEENT - NC AT Heart - S1 S2 RRR Lung - Moderate air entry Abdomen - Soft, non-tender, BS+ Ext - No LE edema Neuro - AAO x3"
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old male patient received BNT162b2 (BNT162B2), on 03Jan2021 at 11:00 as dose 1, single (Batch/Lot number: unknown), in left arm, on 24Jan2021 at 10:00 as dose 2, single (Batch/Lot number: unknown), in left arm, on 16Aug2021 at 13:00 as dose 3 (booster) , single (Batch/Lot number: unknown), in left arm and on 08Feb2022 at 13:00 as dose 4 (booster) , single (Batch/Lot number: unknown) at the age of 75 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of vaccination failure, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Arm- swelling 3 X its size right arm shoulder back forearm elbow breast, Infection throughout, fever extreme pain,muscle, pain, nausea, headache, dizziness.
Pt states she had a low grade fever on 10/20/09. On 10/25/09 noticed Lt side of face was drooping. Went to her OB-GYN provider. Diagnosed with Bell's Palsy.11/19/2009 OB GYN visit for 11/18/2009 stated facial weakness resolved, no notes for a prior visit, no tx noted.
Normal arm soreness went away after about 3 days, but returned about a week later and is still continuing.  Nothing visible on the skin.  No lump or soreness upon touching arm.  Mostly sore when using upper arm muscle, such as when holding my tablet for an extended time.  Also sore when I sleep on my left side, enough to disturb my sleep.   Occurs all night and happens roughly 2-3 days per week.
Area of raised erythema approximately 2 inches wide x 3" long (R) upper arm-Hep B #1 given same arm above site (Hx breast CA (L) side).
Date of death: 7/26/2022  COVID + death Admitted on 7/22/2022 Tested positive: 7/22/2022 Admit diagnosis: Respiratory Distress
Information has been received from a physician concerning a 62 year old male with penicillin and ramipril allergy, hypertension, hyperlipid, hepatitis A, hepatitis B and hepatitis C who on 14-AUG-2007 at 9:56AM was vaccinated with the first dose of ZOSTAVAX (lot#: 658207/0883U) 0.65ml subcutaneously in the left arm. Concomitant therapy included simvastatin (MSD), TOPROL XL TABLETS and aspirin. On 06-JUN-2008 the patient noticed a rash on the left side of his waist (at the T10 area). No fever was noted. The patient did not see a doctor. Subsequently, scabs developed and the patient recovered. The patient was Hepatitis A, B, C antibody positive and Hepatitis B antigen negative. No further information is available.
shingles; This is a spontaneous report from a Pfizer-sponsored program  from a contactable consumer (patient).  A male patient of an unspecified age received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 10Feb2021 at single dose as Covid-19 Vaccine. The patient's medical history and concomitant medications were not reported. The patient got his 1st dose on 10Feb2021 and he wanted to know if there were any complications because 2 weeks before his 2nd dose appointment he would be having a shot for his shingles. The outcome of event was unknown.  Information about Lot/batch number has been requested.
pt recv vax;p/ waking up fr nap,had some swelling in face,lasting 1 hr;devel T 102;motrin given;gave sponge bath;T slowly went down;